ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ATHA Athira Pharma Inc

1.99
0.02 (1.02%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Athira Pharma Inc ATHA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.02 1.02% 1.99 06:00:13
始値 安値 高値 終値 前日終値
2.00 1.99 2.05 2.04 1.97
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1520:00GLOBEAthira Pharma Appoints Javier San Martin, M.D., as Chief..
2024/4/1120:00GLOBEAthira Pharma Announces Publication of Preclinical Data..
2024/4/0320:00GLOBEAthira Pharma Announces Upcoming Poster Presentation at..
2024/3/0821:00GLOBEAthira Pharma Presents Clinical and Preclinical Data..
2024/2/2306:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2306:10EDGAR2Form 8-K - Current report
2024/2/2306:05GLOBEAthira Pharma Reports Full Year 2023 Financial Results and..
2024/2/1707:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:40EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2024/2/0906:02GLOBEAthira Pharma Announces Publication in Frontiers in..
2024/1/0906:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0821:11EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBEAthira Pharma Provides 2024 Clinical Pipeline Outlook and..
2024/1/0321:00GLOBEAthira Pharma Completes Enrollment of Phase 2/3 LIFT-AD..
2023/12/1221:00GLOBEAthira Pharma Announces Encouraging Results from SHAPE Phase..
2023/11/2921:00GLOBEAthira Pharma to Participate in Sidoti December Small Cap..
2023/11/2821:00GLOBEAthira Pharma Announces Upcoming Presentation at Motor..
2023/11/1522:15GLOBEAthira Pharma Presents Preclinical Data Highlighting..
2023/11/1006:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:10EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBEAthira Pharma Reports Third Quarter 2023 Financial Results..
2023/11/0821:00GLOBEAthira Pharma to Participate in Jefferies London Healthcare..
2023/10/0605:30GLOBEAthira Pharma Presents Preclinical Data Further Supporting..
2023/9/2820:00GLOBEAthira Pharma to Participate in Upcoming October Conferences
2023/9/1920:00GLOBEAthira Pharma to Participate in the 2023 Cantor Fitzgerald..
2023/8/1105:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:10EDGAR2Form 8-K - Current report
2023/8/1105:05GLOBEAthira Pharma Reports Second Quarter 2023 Financial Results..
2023/7/1720:00GLOBEAthira Pharma Presents Phase 2 Clinical Data Correlating..
2023/7/0620:00GLOBEAthira Pharma Announces Upcoming Presentations at the..
2023/5/3120:00GLOBEAthira Pharma to Participate in Upcoming June Conferences
2023/5/2220:00GLOBEAthira Pharma Appoints Andrew Gengos as Chief Financial..
2023/5/1205:05GLOBEAthira Pharma Reports First Quarter 2023 Financial Results..
2023/5/0820:00GLOBEAthira Pharma to Participate in Upcoming May Investor..

最近閲覧した銘柄

Delayed Upgrade Clock